One of the limitations in our study was the evaluation of solely the clinical outcomes; so, further studies are required to evaluate the therapeutic effects of nano‐curcumin on gingivitis and periodontitis by the means of assessing inflammatory mediators such as TNF‐α and interleukins. This evidence concerns the gene TNF and periodontitis.